Reduced cell attachment to poly(2-hydroxyethyl methacrylate)-coated ventricular catheters in vitro
Corresponding Author
Brian W. Hanak
Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
Department of Neurological Surgery, University of Washington, Seattle, Washington
Brian W. Hanak and Chia-Yun Hsieh are co-first authors.
Correspondence to: Brian W. Hanak, e-mail: [email protected]Search for more papers by this authorChia-Yun Hsieh
Department of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania
Brian W. Hanak and Chia-Yun Hsieh are co-first authors.
Search for more papers by this authorWilliam Donaldson
Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
Search for more papers by this authorSamuel R. Browd
Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
Department of Neurological Surgery, University of Washington, Seattle, Washington
Search for more papers by this authorKenneth K. S. Lau
Department of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania
Search for more papers by this authorWilliam Shain
Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
Search for more papers by this authorCorresponding Author
Brian W. Hanak
Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
Department of Neurological Surgery, University of Washington, Seattle, Washington
Brian W. Hanak and Chia-Yun Hsieh are co-first authors.
Correspondence to: Brian W. Hanak, e-mail: [email protected]Search for more papers by this authorChia-Yun Hsieh
Department of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania
Brian W. Hanak and Chia-Yun Hsieh are co-first authors.
Search for more papers by this authorWilliam Donaldson
Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
Search for more papers by this authorSamuel R. Browd
Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
Department of Neurological Surgery, University of Washington, Seattle, Washington
Search for more papers by this authorKenneth K. S. Lau
Department of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania
Search for more papers by this authorWilliam Shain
Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
Search for more papers by this authorAbstract
The majority of patients with hydrocephalus are dependent on ventriculoperitoneal shunts for diversion of excess cerebrospinal fluid. Unfortunately, these shunts are failure-prone and over half of all life-threatening pediatric failures are caused by obstruction of the ventricular catheter by the brain's resident immune cells, reactive microglia and astrocytes. Poly(2-hydroxyethyl methacrylate) (PHEMA) hydrogels are widely used for biomedical implants. The extreme hydrophilicity of PHEMA confers resistance to protein fouling, making it a strong candidate coating for ventricular catheters. With the advent of initiated chemical vapor deposition (iCVD), a solvent-free coating technology that creates a polymer in thin film form on a substrate surface by introducing gaseous reactant species into a vacuum reactor, it is now possible to apply uniform polymer coatings on complex three-dimensional substrate surfaces. iCVD was utilized to coat commercially available ventricular catheters with PHEMA. The chemical structure was confirmed on catheter surfaces using Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy. PHEMA coating morphology was characterized by scanning electron microscopy. Testing PHEMA-coated catheters against uncoated clinical-grade catheters in an in vitro hydrocephalus catheter bioreactor containing co-cultured astrocytes and microglia revealed significant reductions in cell attachment to PHEMA-coated catheters at both 17-day and 6-week time points. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1268–1279, 2018.
REFERENCES
- 1 McAllister JP, Williams MA, Walker ML, Kestle JR, Relkin NR, Anderson AM, Gross PH, Browd SR. An update on research priorities in hydrocephalus: Overview of the third National Institutes of Health-sponsored symposium “opportunities for hydrocephalus research: pathways to better outcomes.” J Neurosurg 2015; 123: 1427–1438.
- 2 Aschoff A, Kremer P, Hashemi B, Kunze S. The scientific history of hydrocephalus and its treatment. Neurosurg Rev 1999; 22: 67–93; discussion 4-5.
- 3 Lutz BR, Venkataraman P, Browd SR. New and improved ways to treat hydrocephalus: Pursuit of a smart shunt. Surg Neurol Int 2013; 4(Suppl. 1): S38–S50.
- 4 Browd SR, Gottfried ON, Ragel BT, Kestle JR. Failure of cerebrospinal fluid shunts: Part II: Overdrainage, loculation, and abdominal complications. Pediatr Neurol 2006; 34: 171–176.
- 5 Scott RM, Madsen JR. Shunt technology: contemporary concepts and prospects. Clin Neurosurg 2003; 50: 256–267.
- 6 Pollack IF, Albright AL, Adelson PD. A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group. Neurosurgery. 1999; 45: 1399–1408; discussion 408-11.
- 7 Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, Piatt J, Haines S, Schiff S, Cochrane D, Steinbok P. Long-term follow-up data from the shunt design trial. Pediatr Neurosurg 2000; 33: 230–236.
- 8 Hanak BW, Ross EF, Harris CA, Browd SR, Shain W. Toward a better understanding of the cellular basis for cerebrospinal fluid shunt obstruction: Report on the construction of a bank of explanted hydrocephalus devices. J Neurosurg Pediatr 2016; 18: 213–223.
- 9 Bruni JE, Del Bigio MR. Reaction of periventricular tissue in the rat fourth ventricle to chronically placed shunt tubing implants. Neurosurgery 1986; 19: 337–345.
- 10 Del Bigio MR, Bruni JE. Reaction of rabbit lateral periventricular tissue to shunt tubing implants. J Neurosurg 1986; 64: 932–940.
- 11 Del Bigio MR, Fedoroff S. Short-term response of brain tissue to cerebrospinal fluid shunts in vivo and in vitro. J Biomed Mater Res 1992; 26: 979–987.
- 12 Del Bigio MR. Biological reactions to cerebrospinal fluid shunt devices: a review of the cellular pathology. Neurosurgery 1998; 42: 319–325; discussion 25-6.
- 13 Sarkiss CA, Sarkar R, Yong W, Lazareff JA. Time dependent pattern of cellular characteristics causing ventriculoperitoneal shunt failure in children. Clin Neurol Neurosurg 2014; 127: 30–32.
- 14 Hanak BW, Bonow RH, Harris CA, Browd SR. Cerebrospinal fluid shunting complications in children. Pediatr Neurosurg 2017 [Epub ahead of print].
- 15 Sekhar LN, Moossy J, Guthkelch AN. Malfunctioning ventriculoperitoneal shunts. Clinical and pathological features. J Neurosurg 1982; 56: 411–416.
- 16 Blegvad C, Skjolding AD, Broholm H, Laursen H, Juhler M. Pathophysiology of shunt dysfunction in shunt treated hydrocephalus. Acta Neurochir (Wien) 2013; 155: 1763–1772.
- 17 Harris CA, Resau JH, Hudson EA, West RA, Moon C, Black AD, McAllister JP. Reduction of protein adsorption and macrophage and astrocyte adhesion on ventricular catheters by polyethylene glycol and N-acetyl-L-cysteine. J Biomed Mater Res A 2011; 98: 425–433.
- 18 Harris CA, McAllister JP, 2nd. Does drainage hole size influence adhesion on ventricular catheters? Childs Nerv Syst 2011; 27: 1221–1232.
- 19 Kestle JR, Holubkov R, Douglas Cochrane D, Kulkarni AV, Limbrick DD, Jr, Luerssen TG, Jerry Oakes W, Riva-Cambrin J, Rozzelle C, Simon TD, Walker ML. A new hydrocephalus clinical research network protocol to reduce cerebrospinal fluid shunt infection. J Neurosurg Pediatr 2016; 17: 391–396.
- 20 Konstantelias AA, Vardakas KZ, Polyzos KA, Tansarli GS, Falagas ME. Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis. J Neurosurg 2015; 122: 1096–1112.
- 21 Cagavi F, Akalan N, Celik H, Gur D, Guciz B. Effect of hydrophilic coating on microorganism colonization in silicone tubing. Acta Neurochir (Wien) 2004; 146: 603–610; discussion 9-10.
- 22 Kaufmann AM, Lye T, Redekop G, Brevner A, Hamilton M, Kozey M, Easton D. Infection rates in standard vs. hydrogel coated ventricular catheters. Can J Neurol Sci 2004; 31: 506–510.
- 23 Kestle JR, Riva-Cambrin J, Wellons JC, III, Kulkarni AV, Whitehead WE, Walker ML, Oakes WJ, Drake JM, Luerssen TG, Simon TD, Holubkov R. A standardized protocol to reduce cerebrospinal fluid shunt infection: The hydrocephalus clinical research network quality improvement initiative. J Neurosurg Pediatr 2011; 8: 22–29.
- 24 CA Harris, editor. The cellular and tissue response affecting catheters used in the treatment of hydrocephalus. Seventh meeting of the International Society for Hydrocephalus and CSF Disorders. Canada; 2015.
- 25 Wichterle L, Lim O. Hydrophilic gels for biological use. Nature 1960; 185: 117–118.
- 26 Ferreira L, Vidal MM, Gil MH. Evaluation of poly(2-hydroxyethyl methacrylate) gels as drug delivery systems at different pH values. Int J Pharm 2000; 194: 169–180.
- 27 Lu S, Anseth KS. Photopolymerization of multilaminated poly(HEMA) hydrogels for controlled release. J Control Release 1999; 57: 291–300.
- 28 Nicolson PC, Vogt J. Soft contact lens polymers: An evolution. Biomaterials 2001; 22: 3273–3283.
- 29 Buwalda SJ, Boere KW, Dijkstra PJ, Feijen J, Vermonden T, Hennink WE. Hydrogels in a historical perspective: from simple networks to smart materials. J Control Release 2014; 190: 254–273.
- 30 Song J, Saiz E, Bertozzi CR. A new approach to mineralization of biocompatible hydrogel scaffolds: An efficient process toward 3-dimensional bonelike composites. J Am Chem Soc 2003; 125: 1236–1243.
- 31 Filmon R, Grizon F, Basle MF, Chappaard D. Effects of negatively charged groups (carboxymethyl) on the calcification of poly(2-hydroxyethyl methacrylate). Biomaterials 2002; 23: 3053–3059.
- 32 Jhaveri SJ, Hynd MR, Dowell-Mesfin N, Turner JN, Shain W, Ober CK. Release of nerve growth factor from HEMA hydrogel-coated substrates and its effect on the differentiation of neural cells. Biomacromolecules 2009; 10: 174–183.
- 33 Cook AD, Sagers RD, Pitt WG. Bacterial adhesion to poly(HEMA)-based hydrogels. J Biomed Mater Res 1993; 27: 119–126.
- 34 Wong TT LL, Liu RS, Yeh SH, Chang T, Ho DM, Niu GC, Wang YJ. Hydrogel Ventriculo-Subdural Shunt for the Treatment of Hydrocephalus in Children. Japan: Springer; 1991.
- 35 Chan K, Gleason KK. Initiated chemical vapor deposition of linear and cross-linked poly(2-hydroxyethyl methacrylate) for use as thin-film hydrogels. Langmuir 2005; 21: 8930–8939.
- 36
Gleason KK. CVD Polymers: Fabrication of Organic Surfaces and Devices. United States: John Wiley & Sons; 2015.
10.1002/9783527690275 Google Scholar
- 37 Nejati S, Lau KK. Pore filling of nanostructured electrodes in dye sensitized solar cells by initiated chemical vapor deposition. Nano Lett 2011; 11: 419–423.
- 38 Barr MC, Rowehl JA, Lunt RR, Xu J, Wang A, Boyce CM, Im SG, Bulovic V, Gleason KK. Direct monolithic integration of organic photovoltaic circuits on unmodified paper. Adv Mater 2011; 23: 3499–3505.
- 39 Park H, Howden RM, Barr MC, Bulovic V, Gleason K, Kong J. Organic solar cells with graphene electrodes and vapor printed poly(3,4-ethylenedioxythiophene) as the hole transporting layers. ACS Nano 2012; 6: 6370–6377.
- 40 Lau KK BJ, Teo KB, Chhowalla M, Amaratunga GA, Milne WI, McKinley GH, Gleason KK. Superhydrophobic carbon nanotube forests. Nano Lett 2003; 3: 1701–1705.
- 41 Laird ED, Bose RK, Wang W, Lau KK, Li CY. Carbon nanotube-directed polytetrafluoroethylene crystal growth via initiated chemical vapor deposition. Macromol Rapid Commun 2013; 34: 251–256.
- 42 Olceroglu E, Hsieh CY, Rahman MM, Lau KK, McCarthy M. Full-field dynamic characterization of superhydrophobic condensation on biotemplated nanostructured surfaces. Langmuir 2014; 30: 7556–7566.
- 43 Sojoudi H, Wang M, Boscher ND, McKinley GH, Gleason KK. Durable and scalable icephobic surfaces: Similarities and distinctions from superhydrophobic surfaces. Soft Matter 2016; 12: 1938–1963.
- 44 Hsieh CY LK. Growth of polyglycidol in porous TiO2 nanoparticle networks via initiated chemical vapor deposition: Probing polymer confinement under high nanoparticle loading. Adv Mater Interfaces 2015; 2. DOI: 10.1002/admi.201500341
- 45 Yang R, Jang H, Stocker R, Gleason KK. Synergistic prevention of biofouling in seawater desalination by zwitterionic surfaces and low-level chlorination. Adv Mater 2014; 26: 1711–1718.
- 46 Frampton JP, Hynd MR, Vargun A, Roysam B, Shain W. An in vitro system for modeling brain reactive responses and changes in neuroprosthetic device impedance. Conf Proc IEEE Eng Med Biol Soc 2009; 2009: 7155–7158.
- 47 You JB, Min KI, Lee B, Kim DP, Im SG. A doubly cross-linked nano-adhesive for the reliable sealing of flexible microfluidic devices. Lab Chip 2013; 13: 1266–1272.
- 48 Ozaydin-Ince G, Dubach JM, Gleason KK, Clark HA. Microworm optode sensors limit particle diffusion to enable in vivo measurements. Proc Natl Acad Sci U S A 2011; 108: 2656–2661.
- 49 Ince GO, Armagan E, Erdogan H, Buyukserin F, Uzun L, Demirel G. One-dimensional surface-imprinted polymeric nanotubes for specific biorecognition by initiated chemical vapor deposition (iCVD). ACS Appl Mater Interfaces 2013; 5: 6447–6452.
- 50 Lau KK, Gleason KK. All-dry synthesis and coating of methacrylic acid copolymers for controlled release. Macromol Biosci 2007; 7: 429–434.
- 51 McInnes SJ, Szili EJ, Al-Bataineh SA, Xu J, Alf ME, Gleason KK, Short RD, Voelcker NH. Combination of iCVD and porous silicon for the development of a controlled drug delivery system. ACS Appl Mater Interfaces 2012; 4: 3566–3574.
- 52 O'Shaughnessy WS, Murthy SK, Edell DJ, Gleason KK. Stable biopassive insulation synthesized by initiated chemical vapor deposition of poly(1,3,5-trivinyltrimethylcyclotrisiloxane). Biomacromolecules 2007; 8: 2564–2570.
- 53 Bose RK NS, Stufflet DR, Lau KK. Graft polymerization of anti-fouling PEO surfaces by liquid-free initiated chemical vapor deposition. Macromolecules 2012; 45: 6915–6922.
- 54 Yang R AA, Gleason KK. Design of conformal, substrate-independent surface modification for controlled protein adsorption by chemical vapor deposition (CVD). Soft Matter 2012; 8: 31–43.
- 55 Martin TP, Kooi SE, Chang SH, Sedransk KL, Gleason KK. Initiated chemical vapor deposition of antimicrobial polymer coatings. Biomaterials 2007; 28: 909–915.
- 56 DiTizio V, Ferguson GW, Mittelman MW, Khoury AE, Bruce AW, DiCosmo F. A liposomal hydrogel for the prevention of bacterial adhesion to catheters. Biomaterials 1998; 19: 1877–1884.
- 57 Bose RK, Lau KK. Mechanical properties of ultrahigh molecular weight PHEMA hydrogels synthesized using initiated chemical vapor deposition. Biomacromolecules 2010; 11: 2116–2122.
- 58 Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 1990; 27: 229–237.
- 59 Stansley B, Post J, Hensley K. A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease. J Neuroinflam 2012; 9: 115.
- 60 Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999; 20: 45–53.
- 61 Kuo CK, Ma PX. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: Part 1. Structure, gelation rate and mechanical properties. Biomaterials 2001; 22: 511–521.
- 62 Frampton JP, Hynd MR, Williams JC, Shuler ML, Shain W. Three-dimensional hydrogel cultures for modeling changes in tissue impedance around microfabricated neural probes. J Neural Eng 2007; 4: 399–409.
- 63 Frampton JP, Hynd MR, Shuler ML, Shain W. Fabrication and optimization of alginate hydrogel constructs for use in 3D neural cell culture. Biomed Mater 2011; 6: 015002.
- 64 Nunamaker EA, Kipke DR. An alginate hydrogel dura mater replacement for use with intracortical electrodes. J Biomed Mater Res B Appl Biomater 2010; 95: 421–429.
- 65 Gage GJ, Kipke DR, Shain W. Whole animal perfusion fixation for rodents. J Vis Exp 2012; 65: e3564–e3564.
- 66 Odian G. Principles of Polymerization. United States: John Wiley & Son; 2004.
- 67 Beamson GBD. High Resolution XPS of Organic Polymers. United States: Wiley; 1992.
- 68 Babar S LT, Abelson JR. Role of nucleation layer morphology in determining the statistical roughness of CVD-grown thin films. J Vac Sci Technol A. 2014; 32: 060601.
- 69 Babar S KN, Zhang P, Abelson JR, Dunbar AC, Daly SR, Girolami GS. Growth inhibitor to homogenize nucleation and obtain smooth HfB2 thin films by chemical vapor deposition. Chem Mater 2013; 25: 662–667.
- 70 Craighead HG TS, Davis RC, James C, Perez AM, John PS, Isaacson MS, Kam L, Shain W, Turner JN, Banker G. Chemical and topographical surface modification for control of central nervous system cell adhesion. Biomed Microdev 1998; 1: 49–64.
- 71 Turner AM, Dowell N, Turner SW, Kam L, Isaacson M, Turner JN, Craighead HG, Shain W. Attachment of astroglial cells to microfabricated pillar arrays of different geometries. J Biomed Mater Res 2000; 51: 430–441.
- 72 Minev IR, Moshayedi P, Fawcett JW, Lacour SP. Interaction of glia with a compliant, microstructured silicone surface. Acta Biomater 2013; 9: 6936–6942.
- 73 Janakiraman SFS, Hsieh CY, Smolin YY, Soroush M, Lau KK. Kinetic analysis of the initiated chemical vapor deposition of poly (vinylpyrrolidone) and poly (4-vinylpyridine). Thin Solid Films 2015; 595: 244–250.